MHRA Grants Marketing Authorization for Biogen’s MS Treatment November 26, 2021 Auto Bot News 0 Biogen received MHRA marketing authorization for VUMERITY (diroximel fumarate) for treatment of relapsing-remitting multiple sclerosis (RRMS).
